UnknownNot Applicable

Preliminary Exploration of Thromboelastography in the Monitoring of Anticoagulation in Maintenance Hemodialysis Patients

China200 participantsStarted 2024-01-29

Plain-language summary

Objectives: To investigate the role of thromboelastography parameters (R, K, Angle, MA) in monitoring anticoagulation in maintenance hemodialysis (MHD) patients. Subjects: Two hundred stable MHD patients. Methods: An observational study. Primary outcome: Relationship between thromboelastography parameter R Value and coagulation of hemodialysis circuit and dialyzer. Secondary outcome: Relationship between thromboelastography parameters (K Value, Angle and MA) and coagulation of hemodialysis circuit and dialyzer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. male or female patients aged over 18 years
✓. stable patients undergoing maintenance hemodialysis treatment for at least 3 months
✓. signed informed consent form

Exclusion criteria

✕. concomitant with severe diseases such as active malignancy, severe liver diseases, systemic infection, etc.
✕. planned or ongoing pregnancy or lactation
✕. unsuitable for inclusion in this study after assessment

What they're measuring

thromboelastography parameter R value

Timeframe: 2 hours after hemodialysis began

Trial details

NCT IDNCT06272708

SponsorRenJi Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-29

Contact for this trial

Yiwei Shen, MD

0086-18121099413 shenyiwei08@126.com

View on ClinicalTrials.gov More Thromboelastography trials